Company news
Novogene Co., Ltd. Class A (SSE:688315) news
Novogene Co., Ltd. Class A news releases on 6ix. Latest, Sep 23, 2026: "NOVOGENE CO., LTD."Announcement on Abnormal Fluctuations in Stock Trading
Press releases & updates
"NOVOGENE CO., LTD."Announcement on Abnormal Fluctuations in Stock Trading
September 22, 2026
"NOVOGENE CO., LTD."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
September 10, 2026
"NOVOGENE CO., LTD."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
August 25, 2026
Voluntary Announcement
June 9, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 2, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 8, 2026
Announcement on Revising and Formulating Some Corporate Governance Systems
April 14, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 26, 2026
Announcement on Making Provisions for Asset Impairment for the First Three Quarters of 2025
October 23, 2025
Resolutions of the 1st Extraordinary General Meeting in 2025
September 1, 2025
Ultima Genomics and Gene by Gene Partner to Expand Global Access to High-Quality, Low-Cost Sequencing on the UG 100™ Platform
August 19, 2025
2025 Semi-annual Report
August 14, 2025
Announcement on Result of Shareholding Reduction by Shareholder
July 15, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 3, 2025
Announcement on Resolution of the 1st Meeting of the 4th Board of Supervisors
May 7, 2025
Announcement on Electing Employee Representative Supervisor of the 4th Board of Supervisors
April 28, 2025
2024 Annual Report
April 14, 2025
Announcement on Resolution of the 19th Meeting of the 3rd Board of Supervisors
April 11, 2025
Announcement on Resolution of the 18th Meeting of the 3rd Board of Supervisors
March 21, 2025
Announcement on Plan of Shareholding Reduction by Shareholders
March 19, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 26, 2025
Announcement on Abnormal Fluctuations in Stock Trading
February 17, 2025
Announcement on the Results of Repurchasing Shares through Call Auction
February 5, 2025
Announcement on Changes in Audit Engagement Partner, Signatory Certified Public Accountant, and Quality Control Reviewer
January 14, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
January 2, 2025
Announcement on Convening the Q3 2024 Performance Briefing
November 15, 2024
Report for Q3 2024
October 24, 2024
Announcement on Results of Shareholding Reduction by Shareholders
September 29, 2024
Announcement on Resolution of the 16th Meeting of the 3rd Board of Supervisors
August 21, 2024
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares by 1%
August 15, 2024
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2024
August 14, 2024
Announcement of Novogene Co., Ltd. on the Progress in Repurchasing Shares through Auction
July 1, 2024
Announcement on Re-signing Agreement on Supervision over Raised Funds among Four Parties after Changing Investment Project Financed by Raised Funds
June 17, 2024
Announcement on Proportion of Shares Repurchased through Auction Reaching 1% of Total Share Capital and Progress in Repurchase
June 5, 2024
Announcement on Progress in Repurchasing Shares through Auction
June 3, 2024
Announcement on Implementation of Dividend Distribution of 2023
May 24, 2024
Announcement on Adjusting Distribution Ratio per Share in Profit Distribution Plan of 2023
May 13, 2024
Announcement on Resolutions of 2023 Annual General Meeting
May 6, 2024
Announcement on Circulation of Restricted Shares Issued to Specific Objects
April 16, 2024
Announcement on Estimated Daily Related Transactions in 2024
April 12, 2024